Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
29.6M
-
Shares change
-
+209K
-
Total reported value, excl. options
-
$1.7B
-
Value change
-
+$15.3M
-
Put/Call ratio
-
2.03
-
Number of buys
-
130
-
Number of sells
-
-63
-
Price
-
$57.31
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2019
230 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2019.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.6M shares
of 51.1M outstanding shares and own 57.94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.88M shares), VANGUARD GROUP INC (3.41M shares), STATE STREET CORP (1.67M shares), Redmile Group, LLC (1.42M shares), JPMORGAN CHASE & CO (1.21M shares), PERCEPTIVE ADVISORS LLC (1.15M shares), WS MANAGEMENT LLLP (996K shares), RENAISSANCE TECHNOLOGIES LLC (870K shares), FMR LLC (863K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (721K shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.